Readability & Display

Unofficial consolidated textConsolidated 2026-01-01English

Annex VI

Reproduced from official EUR-Lex 1/1/2026.

Official catalogue · non-binding

Related guidance (23)

Current English catalogue entries that refer to Annex VI. Guidance is non-binding and kept separate from the regulation text.

Browse topics
MDCG 2021-24 rev.1Guidance on classification of medical devicesApril 2026
MDCG 2019-15 rev.1Guidance notes for manufacturers of class I medical devicesDecember 2019
MDCG 2020-6Guidance on sufficient clinical evidence for legacy devicesBackground note on the relationship between MDCG 2020-6 and MEDDEV 2.7/1 rev.4 on clinical evaluationApril 2020
MDCG 2019-9 - rev.1Summary of safety and clinical performanceMarch 2022
MDCG 2020-9Regulatory requirements for ventilators and related accessoriesApril 2020
MDCG 2021-13 rev.1Questions and answers on obligations and related rules for the registration in EUDAMED of actors other than manufacturers, authorised representatives and importers subject to the obligations of Article 31 MDR and Article 28 IVDRJuly 2021
MDCG 2021-1 rev.1Guidance on harmonised administrative practices and alternative technical solutions until EUDAMED is fully functionalMay 2021
MDCG 2021-27 - rev.1Questions and Answers on Articles 13 & 14 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746December 2023
Show all 23 guidance documentsShow only the first 8
MDCG 2022-16Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746October 2022
MDCG 2021-26Q&A on repackaging & relabelling activities under Article 16 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746October 2021
MDCG 2019-7 - rev.1Guidance on article 15 of the medical device regulation (MDR) and in vitro diagnostic device regulation (IVDR) on a ‘person responsible for regulatory compliance’ (PRRC)December 2023
MDCG 2025-8 - rev.1Guidance on the implementation of the Master UDI-DI solution for spectacle frames, spectacle lenses and ready-to-wear reading spectaclesMarch 2026
MDCG 2024-14 - rev.1Guidance on the implementation of the Master UDI-DI solution for contact lensesAugust 2025
MDCG 2022-7Q&A on the Unique Device Identification system under Regulation (EU) 2017/745 and Regulation (EU)May 2022
MDCG 2021-19Guidance note integration of the UDI within an organisation’s quality management systemJuly 2021
MDCG 2021-10The status of Appendixes E-I of IMDRF N48 under the EU regulatory framework for medical devicesJune 2021
MDCG 2018-1 rev.4Guidance on basic UDI-DI and changes to UDI-DIApril 2021
MDCG 2019-2Guidance on application of UDI rules to device-part of products referred to in article 1(8), 1(9) and 1(10) of Regulation 745/2017February 2019
MDCG 2018-7Provisional considerations regarding language issues associated with the UDI databaseOctober 2018
MDCG 2018-5UDI assignment to medical device softwareOctober 2018
MDCG 2018-4Definitions/descriptions and formats of the UDI core elements for systems or procedure packsOctober 2018
MDCG 2018-3 rev.1Guidance on UDI for systems and procedure packsJune 2020
SCHEER guidelinesUpdate on the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devicescovering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) propertiesJune 2024

Reader references